Peptides for Weight Loss: What Actually Works

The peptides with real, FDA-approved weight-loss evidence are the GLP-1 medications: tirzepatide (Zepbound, ~21% average weight loss) and semaglutide (Wegovy, ~15–17%). These are peptides — that’s what people are usually looking for when they search “peptides for weight loss.” They require a prescription and are the only peptides proven to produce significant weight loss.

Yes. Semaglutide and tirzepatide are peptide medications — specifically GLP-1 receptor agonists. So the most effective, FDA-approved “weight-loss peptides” are the same GLP-1 drugs sold as Wegovy, Ozempic, Zepbound, and Mounjaro.

No. BPC-157 is marketed as a “tissue-repair” research peptide; it has never been submitted for FDA approval (no IND on file) and there is no credible evidence it causes weight loss. In September 2023 the FDA placed it on a restricted list; a February 2026 reclassification changed its compounding eligibility, but it is still not FDA-approved, still requires a prescription, and still has no weight-loss evidence. It is not a weight-loss treatment.

No. AOD-9604 is a fragment of human growth hormone that was actually studied as an anti-obesity drug — and it failed: it completed Phase IIb trials without showing enough weight-loss efficacy to win approval. Despite that, it’s still sold online for weight loss. It is not FDA-approved and the evidence says it doesn’t work for this purpose.

Peptides sold online labeled “research use only” or “not for human consumption” are unapproved, unregulated products — purity, dose, and sterility are not verified, and using them is unsafe and legally murky. The only peptides you can be prescribed for weight loss with proven results are the GLP-1 medications, through a licensed clinician. Be very cautious of anyone selling peptides for weight loss outside that path.